key: cord-0810945-s5ine95m authors: Weitzman, Elissa R.; Sherman, Amy C.; Levy, Ofer title: Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary date: 2022-05-17 journal: Clin Infect Dis DOI: 10.1093/cid/ciac343 sha: 0bce4d0fad63c33351af80de9832372c7659e001 doc_id: 810945 cord_uid: s5ine95m Authorization of SARS-CoV-2 vaccines for children has ushered in a new phase of the immunization campaign to address the pandemic but has been received with mixed responses from parents, children, and opinion leaders. Herein we consider perceptions and attitudes towards pediatric SARS-CoV-2 vaccines from FDA public commentary reflecting >63,000 comments. A C C E P T E D M A N U S C R I P T endorsement and diffusion of misinformation, including assertions of substantial known and often 1 hidden patterns of pediatric vaccine injury arising from vaccination for COVID-19, belief that children are 2 not susceptible to nor experience severe COVID, and presumption of financial profiteering driving 3 vaccine promotion (supplemental Table 1 ). Issues of special interest regarding pediatric vaccine 4 approval are discussed below. 5 Many comments directed toward SARS-CoV-2 pediatric vaccination raised difficult questions 7 regarding the risk-benefit ratio for pediatric vaccine approval. Most comments lacked awareness of the 8 broader set of harms befalling children and youth. The ethical complexity of decision-making is 9 heightened where harms to the child may arise via a broad set of harms (i.e., mental health problems, 10 developmental delays): "The risk-benefit analysis for the COVID-19 vaccines points to a high potential 11 risk versus no benefit for children and young people. Transmission of SARS-CoV-2 from children to adults 12 is minimal and adults in contact with children do not have higher COVID-19 mortality. It is unethical to 13 put children and young people at risk to protect adults." Comment focused almost exclusively on 14 mortality rates and did not reflect harms to mental health, development, or persons around children 15 and youth who may be infected through exposure to an infectious child. 16 Absence of evidence and changing epidemiology are especially problematic when decision-18 making is made on behalf of a developing hence vulnerable child. Parents have a natural motivation to 19 protect their children and avoid harm and comments reflected deep parental concern. However, 20 rampant misinformation and misdirection was apparent regarding what's known about the safety of 21 SARS-CoV-2 vaccines for children and youth, and the risks to children and youth from COVID-19. Some 22 worries were grounded in fundamental misconceptions about the relatively new mRNA vaccine 23 platform, with concerns that the vaccine involves "gene therapy." Some commentators asserted they 1 were not "anti-vaxxers" and have ensured standard vaccinations for their children but are concerned 2 about new vaccines: "We are not universally opposed to vaccines. We are absolutely and vehemently 3 opposed to these vaccines being given to children. It is self-evident that these vaccines and their side 4 effects are not well known enough to risk giving them to children." Others reflect the effects of 5 politicization of vaccination and polarization of vaccine-related beliefs. Cynicism regarding big pharma 6 and presumptions of vaccine profiteering were evident too. 7 Consideration of vaccine mandates was not the purview of the US FDA VRBPAC, yet this 9 controversial topic was raised repeatedly in the public comments, and federal committee members 10 received urgent and even threatening messages as part of this process [4] . Confusion was evident 11 regarding the meaning and limits of EUA. On the one hand, comments reflected understanding of 12 authorization as an emergency measure in the setting of crisis and uncertainty, however for some this 13 increased suspicion and mistrust: why authorize something we don't fully understand for use with a 14 vulnerable population? On the other hand, EUA was construed as a step toward or equal to a broad 15 vaccination requirement, with potential to lead to other health mandates: "An EUA of this stature would 16 open the door for all sorts of "Mandates" in schools-forcing every parent who is opposed (there's 17 millions of them!!), to start homeschooling." While the case for pediatric SARS-CoV-2 vaccine mandates 18 has been articulated [5], recommendations regarding mandates were explicitly not part of the VRBPAC 19 charge. Moreover, several committee members expressed their personal views on the public record [6] 20 that they supported authorization of mRNA vaccines for use by families who wished to immunize their 21 children, but that the vaccines should not be mandated for 5-11Y persons at least until more safety data 22 were accumulated-i.e., via post-authorization active and passive surveillance [7] . 23 This rapid thematic assessment revealed substantial and deep public concern regarding 2 pediatric SARS-CoV-2 vaccines. Significant levels of mistrust and opposition to pediatric SARS-CoV-2 3 vaccines were found together with acute concern for ethical and evidentiary challenges to establishing a 4 favorable benefit-to-risk ratio for vaccination. Many comments reflected general openness to vaccines 5 along with questions about the quality of evidence for pediatric SARS-CoV-2 vaccines at this time rather 6 than blanket anti-vaccination views. Opposition centered on worry for children's developmental 7 vulnerability and illustrated low trust, confusion and cynicism about the meaning, limits, and processes 8 of EUA and the governing authorities. Results build on a prior review of concerns expressed in public 9 commentary [3] , where themes regarding vaccine safety and efficacy, trust in and transparency of the 10 processes for developing vaccines, granting EUA, and public health decision-making were apparent. 11 Overwhelmingly, comments ignored or erroneously refuted threats of harm to children from 12 SARS-CoV-2 and COVID-19 disease. While serious outcomes of COVID-19 (e.g., hospitalizations and 13 deaths) are much less frequent in pediatric compared to adult populations [8] , it is estimated that >700 14 children have died of COVID in the U.S. [9] . Rates of SARS-CoV-2 infection have increased in children and 15 adolescents in the period when the Delta variant dominated [10] , with concern that the emergence of 16 Omicron will intensify the burden of pediatric SARS-CoV-2 infection and COVID-19 disease [11] . In 17 addition, little is known regarding potential chronic effects of COVID on children ("long COVID") [12]. 18 Indirect effects of childhood SARS-CoV-2 infection are substantial. Although contradictory information 19 regarding transmissibility of SARS-CoV-2 from children to adults has been published [13, 14] , more 20 recent studies demonstrate transmission to adults, especially by younger infants [15] . Children may 21 transmit SARS-CoV-2 to those in their household who may be more vulnerable to poor outcomes. 22 Disruption of the family on this level is significant, with worse case scenarios resulting in morbidity and 23 mortality among caregivers. It is currently estimated that ~167,000 children in the United States lost a 24 A C C E P T E D M A N U S C R I P T 8 caregiver (parent, custodial grandparent, or grandparent caregiver) due to COVID-19 related deaths 1 [16, 17] . The heavy burden of indirect effects of COVID-19 disease on children includes mental health 2 disorders that stem from school closures, social isolation, and stigma from testing positive [18, 19] , as 3 well as negative effects on child development [20] . Increased emergency department visits for mental 4 health-related events in children less than 18Y has increased during the COVID-19 pandemic [21] , and 5 the pediatric mental health crisis is negatively affecting the healthcare system's capacity to address Solutions are needed to overcome these barriers, including potentially: 1) supported time by 3 major media outlets for delivery of digestible public health guidance during periods of peak viewership, 4 2) moderated discussions at local community centers, school boards, and sites of religious worship 5 regarding public health measures to address the pandemic, 3) investment in sustainable public health 6 communications offices tied to local communities to ensure prepared, credible, and reliable sources of 7 information and guidance, 4) improved surveillance of and response to misinformation transmitted 8 through social media, 5) provision of transparent, thoughtful, accessible and respectful content in media 9 that is popular among parents of children. 10 This rapid thematic analysis of public comments submitted to the VRBPAC for pediatric SARS-12 CoV-2 vaccines provides a high-level summary of major issues of concern by volunteer commentators. Pediatric immunization holds substantial promise to address the SARS-CoV-2 pandemic, 2 especially as new variants of concern emerge. However, difficult questions need attention regarding 3 how we balance risks and benefits and speak to safety concerns for administering novel products to 4 developing youth. Understanding perceptions regarding pediatric SARS-CoV-2 vaccination is crucial to 5 effective communication that supports vaccine decision making. Ultimately, positions supporting and 6 opposing pediatric vaccinations shared the single overarching concern for child wellbeing. 7 Acknowledging shared values and goals may provide the basis for dialogue and progress. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 2 to 11 Years of Age FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in 4 Children 5 through 11 Years of Age. FDA events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-6 children-5-through-11-years-age SARS-CoV-2 mRNA Vaccine Attitudes as Expressed Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Front 9 Public Health hors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&f 12 ield=&journalName=Frontiers_in_Public_Health&id=695807. Accessed 16 Tracking the FDA advisory panel meeting on Covid-19 vaccines for kids Considering Mandatory Vaccination of Children for COVID-19 Vaccines and Related Biological Products Advisory Committee MJ. Hospitalizations Associated with COVID-19 Among Children and Adolescents -COVID 14 States Omicron Variant in South Africa: Kids Under 2 Are 10% of Hospital Cases -Bloomberg How Common is Long COVID in Children and Adolescents? The 10 Science Brief: Transmission of SARS-CoV-2 in K-12 Schools and Early Care and Education 12 ncov/science/science-briefs/transmission_k_12_schools.html. Accessed 29 COVID-19 Transmission and Children: The Child Is Not to Blame Association of Age and Pediatric Household Transmission of 17 SARS-CoV-2 Infection The Hidden U.S. COVID-19 Pandemic: Orphaned Children. 2021. Available at Hidden Pain: Children Who Lost a Parent or Caregiver to COVID-19 and What the Nation Can Do To 22 Risk and Protective Factors 25 for Prospective Changes in Adolescent Mental Health during the COVID-19 Pandemic The potential impact of the COVID-19 pandemic on child growth and development: a systematic review Emergency Department Visits Among Children Aged <18 Years During the COVID-19 Pandemic -8 United States Disruption of medical care among individuals in the southeastern 10 United States during the COVID-19 pandemic Ethics of Vaccination in Childhood-A Framework Based on the Four Principles of 14 Pregnancy and Rubella | CDC Accessed 29 Mumps, Rubella (MMR) Vaccine | CDC. 2021. Available at Why aren't there more academic experts in the media?